Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Licence raj replaced...

    Licence raj replaced by time-consuming approval raj: Biocon CMD Kiran Mazumdar Shaw

    Written by savita thakur thakur Published On 2016-08-02T11:56:00+05:30  |  Updated On 2 Aug 2016 11:56 AM IST
    Licence raj replaced by time-consuming approval raj: Biocon CMD Kiran Mazumdar Shaw

    Hyderabad : India may have created a competitive market by abolishing licence raj, but it has been replaced by an equally time-consuming "approval raj" fraught with potential corruption, Biocon CMD Kiran Mazumdar-Shaw has said.


    Sharing her thoughts on 25 years of economic reforms in India, she said, in the past, businesses had to contend with issue of licences which were time-consuming and cumbersome.


    "Licence raj has been replaced by approval raj. It is about approvals which are also time consuming. Both licences and approvals are fraught with potential corruption and speed money. Hence, the only way to overcome this is self-regulation and deemed approvals on an online platform which removes the human element and thereby reduces corruption," Mazumdar-Shaw said in an interview to PTI.


    She also is of the view that India Inc is over regulated and it is reflected in the country's low ranking in the ease of doing business.


    "We are burdened with far too many applications and approvals and therefore need to move to deemed approvals and self-regulation based on compliance with a stated set of rules," Mazumdar-Shaw, a pioneer of India's biotechnology industry, said.


    "Such self-regulation needs to be captured on an online regulatory register which will provide transparency and traceability," she noted.


    According to her, today automation is boosting efficiency and GDP growth but not creating jobs.


    "This is dangerous. We need to think of sectors and businesses that create jobs. Services are job creators. Manufacturing needs to be job-oriented too. Agarbattis and beedis create jobs but even these low-end sectors have lost their competitiveness and today India has been overtaken by Vietnam for agarbatti manufacturing," Mazumdar-Shaw said.


    Rapid economic change through automation and new technologies can be disruptive and can boost productivity, but they can also affect jobs market, leading to social tension, she cautioned.


    "We need to be prepared to mitigate these challenges through innovative ways," she added.

    approvalapproval rajBioconIndia's biotechnology industryKiran Mazumdar ShawLicence rajLicences
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok